Stock Picks

Mar. 8, 2026

Rhenman & Partners Asset Management AB Boosts Biogen Stake by 358%

The investment firm now owns $7.7 million in shares of the biotechnology company.

Mar. 3, 2026

Relay Therapeutics Stock Price Rises 6%

Analysts Weigh In on Whether Investors Should Buy the Biotech Stock

Mar. 3, 2026

Mitsubishi UFJ Asset Management Boosts Biogen Holdings

Institutional investor increases stake in biotech firm by 4.5% in Q3

Feb. 28, 2026

HC Wainwright Upgrades Edgewise Therapeutics to Strong Buy

Analysts see multiple near-term catalysts for the biotech company's pipeline

Feb. 27, 2026

Beam Therapeutics Holds Great Potential, But Patience Needed

Biotech firm's base-editing gene therapy and pipeline show promise, but investors must exercise caution